title: Can oral contraceptives cause vestibulodynia?
abstract: OBJECTIVE
  To describe the clinical course of a young woman who developed vestibulodynia with introital dyspareunia while on oral contraceptive (OCs) and to provide a possible explanation for the etiology of her symptoms as well as her recovery after treatment.
  
  
  METHODS
  A single case is presented including subjective reporting, laboratory evaluation, and quantitative sensory testing.
  
  
  RESULTS
  After topical hormonal therapy, the patient reported resolution of her dyspareunia and and her laboratory values normalized.
authors.affiliation: The Center for Vulvovaginal Disorders, Washington, DC, USA. obstetrics@yahoo.com
authors.forename: Andrew
authors.initials: A
authors.lastname: Goldstein
authors.forename: Lara
authors.initials: L
authors.lastname: Burrows
authors.forename: Irwin
authors.initials: I
authors.lastname: Goldstein
mesh_terms: D000282:Administration, Intravaginal; D000328:Adult; D003075:Coitus; D004414:Dyspareunia / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D004958:Estradiol / Q000008:administration & dosage / Q000097:blood; D005260:Female; D006801:Humans; D012102:Reproductive Control Agents / Q000008:administration & dosage / Q000009:adverse effects*; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism; D013739:Testosterone / Q000008:administration & dosage / Q000097:blood; D056650:Vulvodynia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D012102:Reproductive Control Agents; D012738:Sex Hormone-Binding Globulin; D013739:Testosterone; D004958:Estradiol